Alpelisib is a PI3K enzyme inhibitor. It’s meant for breast cancer patients who are HR and HER2- with PIK3CA mutations. It works by focusing on the PI3K signaling pathway.
You can get it in three doses: 50, 200, and 300 milligrams, all in film-coated tablet form. The suggested amount to take each day is 300 mg, and you should take it with your meals. Each blister pack has 28 tablets.
That’s a whole month’s worth of the recommended dose.
